Nasdaq Pstv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq pstv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pstv Today - Breaking & Trending Today

Short Interest in Plus Therapeutics, Inc. (NASDAQ:PSTV) Declines By 25.3%

Plus Therapeutics, Inc. (NASDAQ:PSTV – Get Free Report) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 43,300 shares, a decline of 25.3% from the January 15th total of 58,000 shares. Currently, 1.0% of the shares of the company are […] ....

Schonfeld Strategic Advisors , Millennium Management , Renaissance Technologies , Therapeutics Inc , Vanguard Group Inc , Plus Therapeutics , Get Free Report , Strategic Advisors , Plus Therapeutics Daily , Nasdaq Pstv ,

Contrasting SANUWAVE Health (OTCMKTS:SNWV) and Plus Therapeutics (NASDAQ:PSTV)

Plus Therapeutics (NASDAQ:PSTV – Get Free Report) and SANUWAVE Health (OTCMKTS:SNWV – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability. Insider & Institutional Ownership 3.5% of Plus […] ....

United States , Eden Prairie , Cytori Therapeutics Inc , Therapeutics Inc , Health Inc , Plus Therapeutics , Get Free Report , Given Plus Therapeutic , Liposome Biodegradable Alginate Microsphere , Texas Health Science Center , Cytori Therapeutics , Plus Therapeutics Daily , Nasdaq Pstv , Stock Comparison , Stock Analysis ,

Plus Therapeutics, Inc. (NASDAQ:PSTV) Director Greg Petersen Purchases 20,000 Shares

Plus Therapeutics, Inc. (NASDAQ:PSTV – Get Free Report) Director Greg Petersen purchased 20,000 shares of the company’s stock in a transaction on Monday, September 11th. The stock was bought at an average price of $1.70 per share, for a total transaction of $34,000.00. Following the completion of the purchase, the director now directly owns 24,166 […] ....

Greg Petersen , Schonfeld Strategic Advisors , Therapeutics Inc , Vanguard Group Inc , Millennium Management , Renaissance Technologies , Plus Therapeutics , Get Free Report , Director Greg Petersen , Therapeutics Trading Down , Strategic Advisors , Vanguard Group , Plus Therapeutics Daily , Nasdaq Pstv , Insider Trading , Nsider Trades ,

Q3 2023 EPS Estimates for Plus Therapeutics, Inc. Raised by HC Wainwright (NASDAQ:PSTV)

Plus Therapeutics, Inc. (NASDAQ:PSTV – Free Report) – Research analysts at HC Wainwright upped their Q3 2023 earnings per share (EPS) estimates for shares of Plus Therapeutics in a research note issued on Tuesday, August 15th. HC Wainwright analyst S. Lee now forecasts that the company will earn ($0.58) per share for the quarter, up […] ....

Vanguard Group Inc , Therapeutics Inc , Schonfeld Strategic Advisors , Maxim Group , Renaissance Technologies , Millennium Management , Plus Therapeutics , Free Report , Plus Therapeutic , Get Free Report , Therapeutics Trading Down , Plus Therapeutics Daily , Nasdaq Pstv , Earnings Estimates , Hc Wainwright ,